The Brazilian medical devices authority (ANVISA) approval for Optomed’s handheld fundus camera enables commercial activities of the Optomed Aurora camera in the Brazilian market. Optomed has earlier signed a distribution collaboration agreement with a company focusing on the sales of ophthalmic instruments in the Latin American market, so sales to Brazil can start immediately.
Ms. Laura Piila, Vice President Devices comments:”We have been expecting this registration for several months as Brazil is the most attractive of the Latin American markets and we have had demand for our cameras already since the beginning of our distribution collaboration. Now that we have the registration in place, we can start the launch activities of our Aurora camera also in the Latin American market.”
Optomed in brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 56 international patents protecting the technology.
Vice President Devices, Optomed Plc